Literature DB >> 27055518

Gastrointestinal manifestations in systemic lupus erythematosus.

M Fawzy1, A Edrees2, H Okasha1, A El Ashmaui1, G Ragab1.   

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disorder characterized by multisystem involvement, including the gastrointestinal (GI) tract. There is a significant variation in the clinical presentation and severity of GI disorders. When GI symptoms present as the initial manifestation of SLE, there is likely to be a delay in the diagnosis. The cause of these GI manifestations in SLE may be the disease, or the side effects of medications, or infections. In this study we investigated the GI manifestations in a group of SLE patients. Our study was conducted on 40 SLE patients and 30 healthy controls to assess the prevalence of GI symptoms in SLE patients. The prevalence of gastrointestinal manifestations in our study was 42.5%. GI manifestations in our SLE patients were: acute abdominal pain (due to pleurisy and peritonitis), 6%; diffuse abdominal pain, 23.5%; epigastric pain, 29%; epigastric pain with vomiting, 23.5%; epigastric pain with chronic constipation, 6%; chronic constipation, 6%; and diffuse abdominal pain with bleeding per rectum, 6%. In our study, we found a higher incidence of Giardia infestation in SLE patients than in healthy controls, and 10% of these patients were asymptomatic. There was more Giardia infestation in patients with GI symptoms as compared with patients with no GI symptoms, with a P value of 0.009. In our study SLE patients with GI symptoms had a peak systolic velocity (cm/s) with a mean of 108.4 ± 32.1 standard deviation (SD) in the celiac Doppler study. Patients without GI symptoms had a peak systolic velocity with a mean of 111.9 ± 37.7 SD, meaning that our patients mostly had no evidence of celiac trunk stenosis, but there was significant difference between SLE patients without GI symptoms and controls, as the mean was higher in SLE patients than in the controls. Also, the celiac end diastolic velocity was higher in both groups of SLE patients with GI symptoms and those without GI symptoms, compared to controls.

Entities:  

Keywords:  Systemic lupus erythematosus; gastrointestinal manifestations; giardiasis

Mesh:

Year:  2016        PMID: 27055518     DOI: 10.1177/0961203316642308

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  11 in total

Review 1.  Gastrointestinal aspects of vasculitides.

Authors:  Medha Soowamber; Adam V Weizman; Christian Pagnoux
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-11-23       Impact factor: 46.802

2.  Gastrointestinal system manifestations in juvenile systemic lupus erythematosus.

Authors:  Hafize Emine Sönmez; Asuman Nur Karhan; Ezgi Deniz Batu; Yelda Bilginer; Ersin Gümüş; Hülya Demir; Aysel Yüce; Seza Özen
Journal:  Clin Rheumatol       Date:  2017-02-16       Impact factor: 2.980

3.  Prevalence and Determinants of Gastrointestinal Manifestations in Patients with Selected Rheumatologic Diseases.

Authors:  Emra Asfuroğlu Kalkan; Çağdaş Kalkan; Sezgin Barutcu; Orhan Küçükşahin; Özge Güçbey; Tankut Köseoğlu; Ateş Şendil; Mevlüt Hamamcı; Ersan Özaslan; İhsan Ateş; Emin Altıparmak; İrfan Soykan
Journal:  Turk J Gastroenterol       Date:  2022-07       Impact factor: 1.555

4.  Celiac disease in patients with systemic lupus erythematosus.

Authors:  Zahra Soltani; Azarakhsh Baghdadi; Mohammad Nejadhosseinian; Seyedeh Tahereh Faezi; Bijan Shahbazkhani; Seyed Ali Mousavi; Kiarash Kazemi
Journal:  Reumatologia       Date:  2021-04-27

5.  Chylous Ascites in Systemic Lupus Erythematosus: A Diagnostic Challenge.

Authors:  Badar Hasan; Talal Asif; Maryam Hasan; Amr F Edrees
Journal:  Cureus       Date:  2017-05-05

6.  The Value of Screening for Celiac Disease in Systemic Lupus Erythematosus: A Single Experience of a Tertiary Medical Center.

Authors:  Fahidah AlEnzi; Mada Yateem; Manal Shaikh; Fahad AlSohaibani; Badryah Alhaymouni; AlShaikh Ahmed; Sulaiman M Al-Mayouf
Journal:  Rheumatol Ther       Date:  2020-07-23

7.  A Report of Chronic Intestinal Pseudo-obstruction Related to Systemic Lupus Erythematosus.

Authors:  Ruiqiang Wang; Bowen Zheng; Biyue Wang; Pupu Ma; Fengmei Chen; Lin Tang
Journal:  Open Med (Wars)       Date:  2018-11-25

8.  The Contribution of Drugs and Helicobacter pylori to Gastric Mucosa Changes in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome.

Authors:  Tatiana M Reshetnyak; Irina A Doroshkevich; Natalia V Seredavkina; Evgeny L Nasonov; Igor V Maev; Vasiliy I Reshetnyak
Journal:  Int J Rheumatol       Date:  2019-05-05

9.  Polyserositis and Acute Acalculous Cholecystitis: An Uncommon Manifestation of Undiagnosed Systemic Lupus Erythematosus.

Authors:  Elena I Obreja; Carlos Salazar; Daniel G Torres
Journal:  Cureus       Date:  2019-06-14

10.  Classifying and diagnosing systemic lupus erythematosus in the 21st century.

Authors:  Martin Aringer; Sindhu R Johnson
Journal:  Rheumatology (Oxford)       Date:  2020-12-05       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.